2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

被引：1342

作者：

Hughes, WT

Armstrong, D

Bodey, GP

Bow, EJ

Brown, AE

Calandra, T

Feld, R

Pizzo, PA

Rolston, KVI

Shenep, JL

Young, LS

机构：

[1] St Jude Childrens Res Hosp, Memphis, TN 38105 USA

[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[3] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

[4] Harvard Univ, Sch Med, Boston, MA USA

[5] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA

[6] Kuzell Inst Arthrit, San Francisco, CA USA

[7] Univ Manitoba, Winnipeg, MB, Canada

[8] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[9] CHU Vaudois, CH-1011 Lausanne, Switzerland

来源：

CLINICAL INFECTIOUS DISEASES | 2002年 / 34卷 / 06期

关键词：

D O I：

10.1086/339215

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This article, prepared by the Infectious Diseases Society of America (IDSA) Fever and Neutropenia Guidelines Panel, updates guidelines established a decade ago by the Infectious Disease Society of America for the use of antimicrobial agents to treat neutropenic patients with unexplained fever [1].

引用

收藏

页码：730 / 751

页数：22

相关论文

共 195 条

[111]

Lyman Gary H., 1998, Current Opinion in Oncology, V10, P291, DOI 10.1097/00001622-199807000-00003

[112] FILGRASTIM IN PATIENTS WITH CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

MAHER, DW ;

LIESCHKE, GJ ;

GREEN, M ;

BISHOP, J ;

STUARTHARRIS, R ;

WOLF, M ;

SHERIDAN, WP ;

KEFFORD, RF ;

CEBON, J ;

OLVER, I ;

MCKENDRICK, J ;

TONER, G ;

BRADSTOCK, K ;

LIESCHKE, M ;

CRUICKSHANK, S ;

TOMITA, DK ;

HOFFMAN, EW ;

FOX, RM ;

MORSTYN, G .

ANNALS OF INTERNAL MEDICINE, 1994, 121 (07) :492-501

[113] RANDOMIZED COMPARISON OF ORAL OFLOXACIN ALONE WITH COMBINATION OF PARENTERAL ANTIBIOTICS IN NEUTROPENIC FEBRILE PATIENTS [J].

MALIK, IA ;

ABBAS, Z ;

KARIM, M .

LANCET, 1992, 339 (8801) :1092-1096

[114] FEASIBILITY OF OUTPATIENT MANAGEMENT OF FEVER IN CANCER-PATIENTS WITH LOW-RISK NEUTROPENIA - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL [J].

MALIK, IA ;

KHAN, WA ;

KARIM, M ;

AZIZ, Z ;

KHAN, MA .

AMERICAN JOURNAL OF MEDICINE, 1995, 98 (03) :224-231

[115] Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole [J].

Marr, KA ;

Seidel, K ;

White, TC ;

Bowden, RA .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) :309-316

[116] IMPROVING TREATMENT OF CHEMOTHERAPY-INDUCED NEUTROPENIC FEVER BY ADMINISTRATION OF COLONY-STIMULATING FACTORS [J].

MAYORDOMO, JI ;

RIVERA, F ;

DIAZPUENTE, MT ;

LIANES, P ;

COLOMER, R ;

LOPEZBREA, M ;

LOPEZ, E ;

PAZARES, L ;

HITT, R ;

GARCIARIBAS, I ;

CUBEDO, R ;

ALONSO, S ;

CORTESFUNES, H .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :803-808

[117] Controlled comparison of BacT/ALERT FAN aerobic medium and BACTEC fungal blood culture medium for detection of fungemia [J].

McDonald, LC ;

Weinstein, MP ;

Fune, J ;

Mirrett, S ;

Reimer, LG ;

Reller, LB .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (02) :622-624

[118] Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: A randomized, placebo-controlled, double-blind, multicenter trial [J].

Menichetti, F ;

Del Favero, A ;

Martino, P ;

Bucaneve, G ;

Micozzi, A ;

Girmenia, C ;

Barbabietola, G ;

Pagano, L ;

Leoni, P ;

Specchia, G ;

Caiozzo, A ;

Raimondi, R ;

Mandelli, F .

CLINICAL INFECTIOUS DISEASES, 1999, 28 (02) :250-255

[119]

Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001

[120] PROSPECTIVE RANDOMIZED EVALUATION OF CIPROFLOXACIN VERSUS PIPERACILLIN PLUS AMIKACIN FOR EMPIRIC ANTIBIOTIC-THERAPY OF FEBRILE GRANULOCYTOPENIC CANCER-PATIENTS WITH LYMPHOMAS AND SOLID TUMORS [J].

MEUNIER, F ;

ZINNER, SH ;

GAYA, H ;

CALANDRA, T ;

VISCOLI, C ;

KLASTERSKY, J ;

GLAUSER, M .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (05) :873-878

← 7 8 9 10 11 12 13 14 15 16 →